NeurOptics® is the worldwide leader in the science of pupillometry. Driven by a passion to help clinicians improve patient outcomes, NeurOptics develops and markets innovative technologies facilitating improved medical decision making and enabling clinical research in critical care medicine, neurology, neurosurgery, emergency medicine, ophthalmology, and research. Headquartered in Irvine, California, NeurOptics, Inc. is represented in over 20 countries worldwide.
Location: United States, California, Irvine
Employees: 51-200
Phone: +1 949-250-9792
Founded date: 1995
Investors 1
| Date | Name | Website |
| - | Aphelion C... | aphelionca... |
Mentions in press and media 3
| Date | Title | Description |
| 13.12.2022 | NeurOptics Neurological Pupil index & Automated Pupillometry Included in European Guidelines for Post-Resuscitation Care | NeurOptics® is the leader in the science of pupillometry and NPi®. Driven by a passion to help clinicians improve patient outcomes, NeurOptics develops and markets innovative technologies facilitating improved medical decision-making. The N... |
| 14.09.2022 | New Study Uses NeurOptics’ Pupillometer to Measure the NPi® Differential, an Earlier Indicator of Neurological Injury | Study shows the NPi® differential is another value measured by the NPi Pupillometer that clinicians should consider when managing critically ill patients IRVINE, CALIF., UNITED STATES, September 14, 2022 /EINPresswire.com/ -- A new peer-rev... |
| 03.05.2022 | NeurOptics Expands Globally, Launching NPi®-300 Automated Pupillometer in 15 International Countries | NeurOptics' NPi®-300, a next-generation pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, is now available globally in 15 countries. NPi-300 Pupillometer & the Neurological Pupil index™ (NPi®) repre... |